✦ LIBER ✦

1115 Outcome 15 years after treatment with one adjuvant cycle of etoposide, bleomycin and cisplatin chemotherapy in patients with high risk nonseminomatous germ cell tumors clinical stage I

✍ Scribed by Vidal Faune, A.; Thalmann, G.N.; Fey, M.; Studer, U.E.

Book ID: 122651550
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 108 KB
Volume: 13
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(14)61095-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP10-09 FIFTEEN YEARS AFTER TREATMENT WI

MP10-09 FIFTEEN YEARS AFTER TREATMENT WITH ONE ADJUVANT CYCLE OF ETOPOSIDE, BLEOMYCIN AND CISPLATIN CHEMOTHERAPY OUTCOMES IN PATIENTS WITH HIGH RISK NONSEMINOMATOUS GERM CELL TUMORS CLINICAL STAGE I. EXTENDED FOLLOW UP OF A PROSPECTIVE SINGLE ARM CLINICAL TRIAL COHORT

✍ Vidal Faune, Alvaro; Thalmann, George N.; Fey, Martin; Studer, Urs E. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 56 KB

Long-Term Followup Results of 1 Cycle of

Long-Term Followup Results of 1 Cycle of Adjuvant Bleomycin, Etoposide and Cisplatin Chemotherapy for High Risk Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis

✍ Westermann, Dirk H.; Schefer, Hubert; Thalmann, George N.; Karamitopoulou-Diaman 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 63 KB

LONG-TERM RESULTS FOLLOWING ADJUVANT CHE

LONG-TERM RESULTS FOLLOWING ADJUVANT CHEMOTHERAPY IN PATIENTS WITH CLINICAL STAGE I TESTICULAR NONSEMINOMATOUS MALIGNANT GERM CELL TUMORS WITH HIGH RISK FACTORS

✍ BOHLEN, DOMINIK; BORNER, MARKUS; SONNTAG, ROLAND W.; FEY, MARTIN F.; STUDER, URS 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 567 KB

535 LONG-TERM FOLLOW-UP RESULTS AFTER ON

535 LONG-TERM FOLLOW-UP RESULTS AFTER ONE CYCLE OF BEP CHEMOTHERAPY IN PATIENTS WITH HIGH RISK CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TESTICULAR TUMOR

✍ P. Westermann; H. Schefer; M. Borner; U.E. Studer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 340 KB

675One cycle of bleomycin, etoposide and

675One cycle of bleomycin, etoposide and cisplatin plus two cycles of etopeside and cisplatin chemotherapy in selected patients with low-volume stage II nonseminomatous germ cell tumour of the testis

✍ Z. Mezvrishvili; D. Nikoleishvili; L. Managadze 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Report of the long-term efficacy of two

Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): A risk adapted protocol of the Hellenic Cooperative Oncology Group

✍ Aristotelis Bamias; Gerassimos Aravantinos; Ioannis Kastriotis; Gerassimos Alivi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 137 KB